Literature DB >> 32339092

Decreased Influenza Incidence under COVID-19 Control Measures, Singapore.

Roy Jiunn Jye Soo, Calvin J Chiew, Stefan Ma, Rachael Pung, Vernon Lee.   

Abstract

We compared indicators of influenza activity in 2020 before and after public health measures were taken to reduce coronavirus disease (COVID-19) with the corresponding indicators from 3 preceding years. Influenza activity declined substantially, suggesting that the measures taken for COVID-19 were effective in reducing spread of other viral respiratory diseases.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; Singapore; coronavirus disease; infectious disease; preventive medicine; respiratory infections; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses

Mesh:

Year:  2020        PMID: 32339092      PMCID: PMC7392467          DOI: 10.3201/eid2608.201229

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


Public health measures, including public education and physical distancing, were implemented in Singapore to reduce transmission of coronavirus disease (COVID-19). However, instead of a lockdown, Singapore kept schools and workplaces open and did not advise the routine use of masks for persons who are well during the initial phase of the outbreak in January–February 2020. We examined the effect of these COVID-19 measures on influenza incidence as a proxy to determine the overall potential reduction in respiratory virus transmission. We obtained routine sentinel surveillance data on influenza-like illnesses (ILI) from a national network of primary care clinics and the National Public Health Laboratory. ILI was defined as fever (>38°C) and cough. Data included number of visits to government primary care clinics for ILI per day, ILI samples tested per week, and percentage influenza positivity. We estimated number of influenza cases per day by multiplying ILI visits per day by the proportion of ILI patients who tested positive for influenza, which better reflects influenza infection rates than either indicator alone (). We compared influenza activity between epidemiologic weeks 1–4 and weeks 5–9 of 2020. Most community-based COVID-19 measures were instituted after the first few cases were reported in epidemiologic week 4, and public awareness was increased (). These measures included cancellation of large-scale events and precautions at schools (e.g., fewer assemblies, no interclass mixing, and staggered meal times) and workplaces (e.g., segregated teams and teleworking wherever possible). Intensive public education on personal hygiene and social responsibility included encouraging regular handwashing and seeking medical attention early when ill. To enable self-isolation and prevent spread, physicians were instructed to give certificates for 5 days of medical leave for patients who had respiratory symptoms but did not meet the COVID-19 suspect case definition. We compared indicators of influenza transmissibility in 2020 against the average from corresponding periods in the 3 preceding epidemiologic years (2016–2019). We performed weekly paired difference t-test using R version 3.5.1 (https://www.r-project.org). Influenza activity peaked in epidemiologic week 1 of 2020 but declined to below the average of the preceding years by epidemiologic week 5 (Figure). Percentage influenza positivity decreased by 64% (p = 0.001) and estimated daily number of influenza cases decreased by 76% (p = 0.002) in epidemiologic weeks 5–9 of 2020 compared with the preceding years. In contrast, we saw no significant changes in any of the indicators, except percentage of influenza positivity (31%; p = 0.008), in epidemiologic weeks 1–4 of 2020 compared with preceding years.
Figure

Indicators of influenza activity during the 2019–20 season (red line) compared with average of the preceding 3 years (green line), Singapore. A) Average number of visits per day to government primary care clinics for influenza-like illnesses, 2016–2020. B) Samples from patients with influenza-like illness tested per week, 2016–2020. C) Influenza positivity, 2016–2020. D) Estimated daily numbers of influenza cases, 2016–2020.

Indicators of influenza activity during the 2019–20 season (red line) compared with average of the preceding 3 years (green line), Singapore. A) Average number of visits per day to government primary care clinics for influenza-like illnesses, 2016–2020. B) Samples from patients with influenza-like illness tested per week, 2016–2020. C) Influenza positivity, 2016–2020. D) Estimated daily numbers of influenza cases, 2016–2020. Public health efforts to control COVID-19 probably reduced influenza transmission in February 2020 because both viruses have similar modes of transmission through respiratory and contact routes. Even if COVID-19 has a potentially higher basic reproduction number (R0) than seasonal influenza (), substantial reduction in transmission could reduce the impact of COVID-19 on healthcare capacity, thereby preventing excess deaths. Our modeling of the effective reproduction number for COVID-19 in Singapore in February 2020 (R. Pung, unpub. data) at 0.5–1 is 55%–77% lower than the mean estimated R0 of 2.2 (). This finding is consistent with the observed 76% reduction in influenza transmission. Our study has several limitations. First, a decrease in influenza transmission is expected in February–March, given the yearly bimodal pattern of influenza incidence in Singapore (). However, the decrease in 2020 is marked compared to previous years. Second, there could be fewer ILI visits to government clinics because of altered health-seeking behavior, or cases may be referred to hospitals and therefore not captured as ILI cases in clinics. However, these missed ILI cases would not affect the proportion positive for influenza. Third, we can infer similar effects on COVID-19 only if the transmission dynamics are similar to influenza. In conclusion, we found a marked decline in ILI in Singapore after the implementation of public health measures for COVID-19. Our findings suggest that such measures are effective in reducing spread of viral respiratory diseases and could mitigate the impact of the COVID-19 pandemic.
  3 in total

1.  Comparability of different methods for estimating influenza infection rates over a single epidemic wave.

Authors:  Vernon J Lee; Mark I Chen; Jonathan Yap; Jocelyn Ong; Wei-Yen Lim; Raymond T P Lin; Ian Barr; Jimmy B S Ong; Tze Minn Mak; Lee Gan Goh; Yee Sin Leo; Paul M Kelly; Alex R Cook
Journal:  Am J Epidemiol       Date:  2011-06-30       Impact factor: 4.897

2.  Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia.

Authors:  Qun Li; Xuhua Guan; Peng Wu; Xiaoye Wang; Lei Zhou; Yeqing Tong; Ruiqi Ren; Kathy S M Leung; Eric H Y Lau; Jessica Y Wong; Xuesen Xing; Nijuan Xiang; Yang Wu; Chao Li; Qi Chen; Dan Li; Tian Liu; Jing Zhao; Man Liu; Wenxiao Tu; Chuding Chen; Lianmei Jin; Rui Yang; Qi Wang; Suhua Zhou; Rui Wang; Hui Liu; Yinbo Luo; Yuan Liu; Ge Shao; Huan Li; Zhongfa Tao; Yang Yang; Zhiqiang Deng; Boxi Liu; Zhitao Ma; Yanping Zhang; Guoqing Shi; Tommy T Y Lam; Joseph T Wu; George F Gao; Benjamin J Cowling; Bo Yang; Gabriel M Leung; Zijian Feng
Journal:  N Engl J Med       Date:  2020-01-29       Impact factor: 176.079

3.  Influenza-associated deaths in tropical Singapore.

Authors:  Angela Chow; Stefan Ma; Ai Ee Ling; Suok Kai Chew
Journal:  Emerg Infect Dis       Date:  2006-01       Impact factor: 6.883

  3 in total
  94 in total

1.  Novel Use of Rapid Antigen Influenza Testing in the Outpatient Setting To Provide an Early Warning Sign of Influenza Activity in the Emergency Departments of an Integrated Health System.

Authors:  Paige M K Larkin; Vladimir Manuel; Naureen Hernandez; Omai B Garner
Journal:  J Clin Microbiol       Date:  2020-11-18       Impact factor: 5.948

2.  Impact of nonpharmaceutical interventions on laboratory detections of influenza A and B in Canada.

Authors:  Philippe Lagacé-Wiens; Claire Sevenhuysen; Liza Lee; Andrea Nwosu; Tiffany Smith
Journal:  Can Commun Dis Rep       Date:  2021-03-31

3.  The association of previous influenza vaccination and coronavirus disease-2019.

Authors:  Ilan Green; Shai Ashkenazi; Eugene Merzon; Shlomo Vinker; Avivit Golan-Cohen
Journal:  Hum Vaccin Immunother       Date:  2020-12-30       Impact factor: 3.452

4.  Impact of COVID-19 outbreak in acute bronchiolitis: Lesson from a tertiary Italian Emergency Department.

Authors:  Antonietta Curatola; Ilaria Lazzareschi; Giulia Bersani; Marcello Covino; Antonio Gatto; Antonio Chiaretti
Journal:  Pediatr Pulmonol       Date:  2021-05-07

5.  Decline in influenza cases in Mexico after the implementation of public health measures for COVID-19.

Authors:  Daniel Arellanos-Soto; Gerardo Padilla-Rivas; Javier Ramos-Jimenez; Kame Galan-Huerta; Sonia Lozano-Sepulveda; Natalia Martinez-Acuña; Consuelo Treviño-Garza; Roberto Montes-de-Oca-Luna; Manuel de-la-O-Cavazos; Ana Maria Rivas-Estilla
Journal:  Sci Rep       Date:  2021-05-24       Impact factor: 4.379

6.  Effects of non-pharmaceutical interventions against COVID-19 on the incidence of other diseases.

Authors:  Olaf Müller; Oliver Razum; Albrecht Jahn
Journal:  Lancet Reg Health Eur       Date:  2021-06-27

7.  COVID-19 emergency in Sicily and intersection with the 2019-2020 influenza epidemic.

Authors:  Fabio Tramuto; Walter Mazzucco; Carmelo Massimo Maida; Giuseppina Maria Elena Colomba; Daniela DI Naro; Federica Coffaro; Giorgio Graziano; Claudio Costantino; Vincenzo Restivo; Francesco Vitale
Journal:  J Prev Med Hyg       Date:  2021-04-29

Review 8.  Latest Effective Measures to Combat COVID-19: A Review.

Authors:  Fei Chen; Yingjie Liu; Bailiu Ya; Jiarui He; Taiyang Leng; Yike Sun; Qing Xin
Journal:  Iran J Public Health       Date:  2021-04       Impact factor: 1.429

Review 9.  Effects of COVID-19 prevention procedures on other common infections: a systematic review.

Authors:  Omid Dadras; Seyed Ahmad Seyed Alinaghi; Amirali Karimi; Mehrzad MohsseniPour; Alireza Barzegary; Farzin Vahedi; Zahra Pashaei; Pegah Mirzapour; Amirata Fakhfouri; Ghazal Zargari; Solmaz Saeidi; Hengameh Mojdeganlou; Hajar Badri; Kowsar Qaderi; Farzane Behnezhad; Esmaeil Mehraeen
Journal:  Eur J Med Res       Date:  2021-07-03       Impact factor: 2.175

10.  Impact of COVID-19 on Heart Failure Hospitalizations.

Authors:  Savalan Babapoor-Farrokhran; Jafar Alzubi; Zachary Port; Naveen Sooknanan; Zaid Ammari; Mohammad Al-Sarie; Behnam Bozorgnia
Journal:  SN Compr Clin Med       Date:  2021-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.